LENZ - LENZ Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LENZ is currently covered by 1 analysts with an average price target of $53.74. This is a potential upside of $14.95 (38.54%) from yesterday's end of day stock price of $38.79.

LENZ Therapeutics's activity chart (see below) currently has 3 price targets and 5 ratings on display. The stock rating distribution of LENZ is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 194 days.

Highest price target for LENZ is $48, Lowest price target is $48, average price target is $48.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 28-Jul-2025. First documented stock forecast 27-Mar-2024.

Best performing analysts who are covering LENZ - LENZ Therapeutics:

Matthew Caufield Joseph Catanzaro

Currently out of the existing stock ratings of LENZ, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$48

$-0.74 (-1.52%)

$38

2 months 13 days ago
(28-Jul-2025)

3/3 (100%)

$16.49 (52.33%)

236

Buy

$36

$-12.74 (-26.14%)

$28

1 years 1 months 26 days ago
(15-Aug-2024)

2/2 (100%)

$13.4 (59.29%)

152

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LENZ (LENZ Therapeutics) average time for price targets to be met?

On average it took 194 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on LENZ (LENZ Therapeutics) with a proven track record?

MATTHEW CAUFIELD

Which analyst has the current lower performing score on LENZ (LENZ Therapeutics) with a proven track record?

JOSEPH CATANZARO

Which analyst has the most public recommendations on LENZ (LENZ Therapeutics)?

Matthew Caufield has 11 price targets and 8 ratings on LENZ

Which analyst is the currently most bullish on LENZ (LENZ Therapeutics)?

Matthew Caufield with highest potential upside - $-0.74

Which analyst is the currently most reserved on LENZ (LENZ Therapeutics)?

Joseph Catanzaro with lowest potential downside - -$12.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?